Gregory Rustowicz
Analyst · Chris Howe with Barrington. Please proceed with your question
Thank you, Rick. Good morning everyone. On Slide 8, net sales in the fourth quarter were $189.5 million. Clearly COVID-19 impacted our business results in the quarter. We were tracking towards our $200 million topline but saw order rates for our short cycle business decline in the second half of March. We estimate that volumes were negatively impacted by about 10 million in the quarter all occurring in the second half of March when countries began the lockdown. Later on the call, Rick will further discuss the COVID-19 impact that we are seeing today. As you know, we completed three divestitures last fiscal year which reduced sales this quarter by $4.8 million compared to last year. Volumes declined by approximately $23 million or 10.8%. While volume was down, our pricing power was evident as we saw year-over-year pricing improve by y 1.3%. About three quarters of this pricing was the result of our 80/20 strategic pricing initiatives. Foreign currency also continued as a headwind and reduced our sales by $2.3 million. Let me provide a little color on sales by region. For the fourth quarter we saw sales volume decline in the U.S. by 13.1%. This was partially offset by prices increases of 1.3%. Sales outside of the U.S. were down 9% adjusting for the effects of divestitures. Solid price improvement of 1.4% partially offset our volume decline of 8%. Sales volume was down in all international regions by mid-to-high single digits as a result of the COVID-19. Turning to orders and backlog, both our short cycle and project based businesses were impacted similarly by COVID-19. Adjusted for divestitures and the impact of foreign currencies, orders were down year-over-year by 11.3%. Sequentially we did see orders improve approximately 10% in both our short cycle and project based businesses. As a result, backlog grew by 4.5% to $131 million from $125 million at the end of December. It is important to note that quoting activity continues at pre-COVID-19 levels, but our sense is that many projects are being delayed especially in the U.S. While there is much uncertainty globally on the effects of COVID-19 and the shape of the recovery, we believe that we have bottomed out in April and encouragingly there are signs that our customers and channel partners are getting back to work globally. As an essential business, all of our factories are operating today. We stand ready to flex production volumes back up at the appropriate time. Our strong market position and leading brands continue to serve us well, especially in times like these. We continue to focus on customer responsiveness and on-time delivery as the channel has reducing inventory levels and this will be more important than ever. On Slide 9, our gross margin was 34.9% in the quarter. On an adjusted basis, eliminating the effects of factory closure costs and business realignment costs, we achieved a record adjusted gross margin for the quarter of 36.1%. For the fiscal year, as Rick mentioned earlier, we achieved a record GAAP gross margin of 35%. We clearly benefited from the 80/20 process which drove $5.5 million of gross profit expansion in the quarter and $20.4 million in the fiscal year through strategic pricing, indirect overhead reductions, and certain volume gains at our targeted accounts. This benefit more than offset the impact of the divestitures, lower sales volumes and lower fixed cost absorption in our factories due to lower sales levels in conjunction with significant inventory reductions that we are undertaking to drive free cash flow. Let's now review the quarter's gross profit bridge. Fourth quarter gross profit of $66.2 million was down $8.9 million compared to the prior year adjusted for the divestures. We did see gross profit expansion from pricing net of material cost inflation and tariffs were lower than the prior year as we imported less Chinese product. We incurred $1.3 million of one-time cost for the factory closures in Ohio and China which was the same amount as the prior year, so this did not have an impact on the gross profit bridge. Foreign currency translation reduced gross profit by $800,000. Productivity net of other cost changes was negative $1.6 million. About half of this negative variance was related to higher Worker's Compensation costs incurred in the quarter related to three old claims. As shown on Slide 10, RSG&A was $46.3 million in the quarter or 24.4% of sales. RSG&A was $2.7 million lower than the previous year. The reduction in RSG&A was due to several factors. Divestitures reduced RSG&A by $4000 and we benefited from FX translation of approximately $600,000. In addition we lowered our RSG&A cost by $3.9 million which was partially offset by $2.2 million of additional cost for the CEO search, higher bad debt accruals and business realignment costs. With the current COVID-19 pandemic we have taken quick and decisive actions to reduce our RSG&A costs in the coming quarters. We have eliminated merit increases, foregone bonus accruals, reduced headcount and significantly reduced travel to name a few. We will monitor market demand and we will add back resources when the timing is right. We will however continue to invest in select growth initiatives as Rick will discuss further. Taking all of this into account, we are forecasting Q1 FY 2021 RSG&A of approximately $39 million. Turning to Slide 11, adjusted operating income was $20.2 million. Adjusted operating margin was 10.7% of sales, an 80 basis point decline from the prior year. The driver of this decline was the impact that COVID-19 had on our sales volume. Decremental operating leverage in the quarter was a negative 17%, which is significantly better than what we saw in the 2009 timeframe. For the year our adjusted operating income declined $2 million and lower revenue of $67 million, yet adjusted operating margin expanded 70 basis points to 12.1%. This represents a decremental margin of 3% which is outstanding performance considering the circumstances. Our Blueprint for Growth Strategy and specifically our 80/20 process and operational excellence initiatives helped to drive this margin expansion. As you can see on Slide 10 GAAP earnings per diluted share for the quarter was $0.39. Adjusted earnings per diluted share was $0.58 compared with $0.69 in the previous year, a decrease of $0.11 per share or about 16%. For the full year adjusted EPS was $2.78 per share, an increase of 1.5%. We expect fiscal 2021's full year tax rate to be approximately 21% to 22%. On Slide 13, we continue to expand our adjusted EBITDA margin. For the year our adjusted EBITDA margin was 15.7%, an increase of 60 basis points from last year. Our return on invested capital was a solid 11.5%, an increase of 30 basis points from last year. Our Blueprint for Growth financial goals of 19% EBITDA margin and mid-teen ROIC remain unchanged. However, the shape of the recovery curve from COVID-19 will determine when we are able to achieve these goals. We continue to utilize our 80/20 process to drive efficiencies, so that when the recovery comes, we will be able to accelerate our growth and further strengthen our margin profile. Moving to Slide 14, you have heard me say many times that one of our hallmarks of Columbus McKinnon Corporation is its ability to generate cash throughout the business cycle. That cash from operating activities for the quarter was $36.5 million, which was a year-over-year increase of $10.8 million or 42%. For fiscal year 2020, we generated a record $97.4 million of free cash flow. This represents about a 45% increase in free cash flow. We were clearly ahead of the curve in reducing our working capital needs heading into the pandemic. We took rapid actions to preserve and generate cash. We drove our working capital as a percent of sales to 14.5% which contributed to the record free cash flow. Going forward, we believe we still have opportunities to reduce our inventory levels further. In addition, we will manage CapEx to $5 million in the first half of the year and we'll reassess our CapEx in the second half of the year based on current economic conditions. Turning to Slide 15, our total debt at the end of the quarter was approximately $251 million and our net debt was $137 million. Our net debt to net total capitalization is now approximately 23%. We repaid the minimum required debt in Q4 of $1 million and plan to pay the minimum required debt in fiscal 2021. We've made excellent progress delevering and have achieved a net debt to adjusted EBITDA leverage ratio of 1.1 times which provides us the financial flexibility to weather the current pandemic. We have a flexible capital structure which is covenant light, which means our financial covenant is only tested if we have outstanding borrowings against our revolver. Subsequent to March 31, we did draw a $25 million on our revolver for liquidity and working capital purposes, while demonstrating that we have a supportive of bank group led by JPMorgan. Please turn to Slide 16 and I will turn it back over to Rick.